MET and non-small cell lung carcinoma: For instance, methylseleninic acid (MSeA) overcomes gefitinib resistance in NSCLC through the asparagine-MET-TOPK axis 143, while ERK2-mediated phosphorylation of TOPK enhances RCC cell sensitivity to sorafenib 52.